Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of real-world usage of lanreotide AUTOGEL 120 in Polish acromegalic patients - results from the prospective 12-month phase of Lanro-Study.
Orlewska E, Kos-Kudła B, Sowiński J, Sworczak K, Zgliczyński W, Andrysiak-Mamos E, Babińska A, Bałdys-Waligórska A, Bandurska-Stankiewicz E, Błaut K, Bolko P, Foltyn W, Jakubczyk D, Jawiarczyk-Przybyłowska A, Junik R, Juraniec O, Lewkowicz E, Lewczuk A, Matyjaszek-Matuszek B, Michałek K, Mucha S, Orłowska-Florek R, Peszel-Barlik M, Pynka S, Rosiek V, Ruchała M, Rutkowska J, Słynko-Krzyzostaniak J, Stefańska A, Strzelczyk J, Syrenicz A, Trofimiuk-Müldner M, Waligórska-Stachura J, Waśko R, Witek P, Zalewska-Rydzkowska D, Zdunowski P, Zemczak A. Orlewska E, et al. Contemp Oncol (Pozn). 2013;17(5):460-5. doi: 10.5114/wo.2013.38805. Epub 2013 Nov 14. Contemp Oncol (Pozn). 2013. PMID: 24596537 Free PMC article.
Therapeutic effect of presurgical treatment with longacting octreotide (Sandostatin® LAR®) in patients with acromegaly.
Bolanowski M, Zgliczyński W, Sowiński J, Bałdys-Waligórska A, Bednarek-Tupikowska G, Witek P, Zieliński G, Liebert W, Siemińska L, Andrysiak-Mamos E, Marek B, Kajdaniuk D, Malicka J, Rosiek V, Jawiarczyk-Przybyłowska A, Investigators CB. Bolanowski M, et al. Endokrynol Pol. 2020;71(4):285-291. doi: 10.5603/EP.a2020.0050. Endokrynol Pol. 2020. PMID: 32901908 Free article.
Pasireotide-a novel somatostatin receptor ligand after 20 years of use.
Bolanowski M, Kałużny M, Witek P, Jawiarczyk-Przybyłowska A. Bolanowski M, et al. Rev Endocr Metab Disord. 2022 Jun;23(3):601-620. doi: 10.1007/s11154-022-09710-3. Epub 2022 Jan 24. Rev Endocr Metab Disord. 2022. PMID: 35067849 Free PMC article. Review.
Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center.
Rolla M, Jawiarczyk-Przybyłowska A, Halupczok-Żyła J, Kałużny M, Konopka BM, Błoniecka I, Zieliński G, Bolanowski M. Rolla M, et al. Front Endocrinol (Lausanne). 2021 Mar 16;12:642131. doi: 10.3389/fendo.2021.642131. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33796075 Free PMC article.
Patients with Active Acromegaly are at High Risk of 25(OH)D Deficiency.
Halupczok-Żyła J, Jawiarczyk-Przybyłowska A, Bolanowski M. Halupczok-Żyła J, et al. Front Endocrinol (Lausanne). 2015 Jun 2;6:89. doi: 10.3389/fendo.2015.00089. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26082755 Free PMC article.
Fibroblast Growth Factor 21 in Patients with Acromegaly.
Halupczok-Żyła J, Jawiarczyk-Przybyłowska A, Skrzypski M, Strowski MZ, Bolanowski M. Halupczok-Żyła J, et al. Exp Clin Endocrinol Diabetes. 2017 Nov;125(10):649-654. doi: 10.1055/s-0043-115647. Epub 2017 Sep 20. Exp Clin Endocrinol Diabetes. 2017. PMID: 28931175
38 results